Protective effect of metformin on cardiomyocytes ischemia-reperfusion (IR) induced apoptosis in rats

Journal of Animal and Veterinary Advances

Volumn 11, Issue 1, 2012, Pages 108-112

  Doustar, Yousef ^a   Mohajeri, Daryoush ^a   Garjani, Alireza ^b   Mousavi, Ghafour ^a   Ghramaleki, Mehrdad Neshat ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Apoptosis; Cardiomyocytes; Iran; Ischemia reperfusion; Metformin; Rat

Indexed keywords

EID: 84856685157     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: 10.3923/javaa.2012.108.112     Document Type: Article

References (16)

1. An, D., G. Kewalramani, J.K. Chan, D. Qi and S. Ghosh et al, 2006. Metformin influence cardiomyocyte cell death by pathway that are dependent and independent of caspase-3. Diabetologia, 49:2174-2184.
2. Bhamra, G.S., D.J. Hausenloy, S.M. Davidson, R.D. Carr and M. Paiva et al., 2008. Metformin protects the ischemie heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res. Cardiol, 103: 274-284.
3. Calvert, J.W., S. Gundewar, S. Jha, J.J.M. Greer, W.H. Bestermann, R. Tian and D.J. Lefer, 2008. Acute metformin therapyconfers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes, 57: 696-705.
4. Dyck, J.R. and G.D. Lopaschuk, 2006. AMPK alterations in cardiac physiology and pathology: Enemy or ally? J. Physiol, 574: 95-112.
5. Frangogiannis, N.G., C.W. Smith and M.L. Entman, 2002. The inflammatory response in myocardial infarction. Cardiovas Res., 53: 31-47.
6. Garjani, A., C.L. Wainwright, I.J. Zeitlin, C. Wilson and S.J. Slee, 1995. Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats. J. Cardiovasc Pharmacol, 25: 634-642.
7. Gottlieb R.A. and R.L. Engler, 1999. Apoptosis in myocardial ischemia-reperfusion. Ann. N. Y. Acad Sci., 874: 412-426.
8. Gundewar, S., J.W. Calvert, S. Jha, I. Toedt-Pingel and S.Y. Ji et al, 2009. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ. Res., 104: 403-411.
9. Hardie, D.G. and D. Carling, 1997. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Blochem., 246: 259-273.
10. Jermendy, G., 2010. New clinical data with metformin therapy in patients with diabetes mellitus. Orv. Hetil, 151: 2025-2030.
11. Legtenberg, R.J., R.J. Houston, B. Oeseburg and P. Smits, 2002. Metformin improves cardiac functional recovery after ischemia in rats. Horm Metab. Res., 34: 182-185.
12. Paiva, M., N.P. Riksen, S.M. Davidson, D.J. Hausenloy and P. Monteiro et al, 2009. Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. J. Cardiovasc. Pharmacol, 53: 373-378.
13. Russell, R.R., J. Li, D.L. Coven, M. Pypaert and C. Zechner et al, 2004. AMP activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis and injury. J. Clin. Invest, 114: 495-503.
14. Sasaki, H., H. Asanuma, M. Fujita, H. Takahama and M. Wakeno et al, 2009. Metformin prevents progression of heart failure in dogs: Role of AMP-activated protein kinase. Circulation, 119: 2568-2577.
15. Solskov, L., B. Lofgren, S.B. Kristiansen, N. Jessen and R. Pold, 2008. Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration. Basic Clin. Pharmacol. Toxicol, 103: 82-87.
16. Su, R.Y., Y. Chao, T.Y. Chen, D.Y. Huang and W.W. Lin, 2007. 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNFá-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling. Mol. Cancer Ther., 6: 1562-1571.